Top Focal Segmental Glomerulosclerosis (FSGS) Treatment Companies

  1. Roche

  2. Genentech

  3. Novartis

  4. Merck

  5. Travere Therapeutics Inc.

*Disclaimer: Top companies sorted in no particular order

Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Major Players

Focal Segmental Glomerulosclerosis (FSGS) Treatment - Competitive Concentration

Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Concentration

List of Focal Segmental Glomerulosclerosis (FSGS) Treatment Companies

  • Roche

  • Genentech

  • Novartis

  • Merck

  • Teva Pharmaceutical Industries

  • Travere Therapeutics Inc.

  • Vertex Pharmaceuticals

  • AstraZeneca

  • Pfizer

  • Bristol-Myers Squibb

  • Otsuka Pharmaceutical Co. Ltd.

  • Equillium Inc.

  • Goldfinch Bio

  • Reata Pharmaceuticals Inc.

  • Ionis Pharmaceuticals

  • Chinook Therapeutics Inc.

  • Omeros Corporation

  • LabCorp

  • Arkana Laboratories

  • Allina Health Laboratory

Get more insights on Focal Segmental Glomerulosclerosis (FSGS) Treatment industry from our comprehensive report